Diet is the most common cause of mild hyperhomocysteinaemia (HHcy), which occurs in approximately 5-7 % of the general population. Since HHcy causes endothelial damage by oxidative stress in different organs, the present study was designed to examine whether HHcy might be involved in renal oxidative stress. Twenty-five male Wistar rats were randomly divided into two groups: one (n 13) was fed ad libitum a folate-free diet (FF) and the other (n 12) was fed the same diet supplemented with folic acid (control, CO). After 8 weeks the animals were killed and kidneys removed. Malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities were measured in plasma and kidney homogenates. Renal tissue sections were analysed by indirect immunostaining with the primary antibody against oxidatively modified LDL receptor (LOX-1). A marked HHcy was confirmed in the FF group. As compared with CO animals, MDA levels in plasma and kidney homogenate were significantly higher in FF rats (P,0·05). Similarly, renal GPx and SOD activities were significantly higher in the FF group (P,0·001). No differences were found in LOX-1 immunohistochemical expression, which in the two groups was displayed in tubular cells. The present study provides evidence that HHcy does produce renal oxidative stress mediated by lipid peroxidation, and that the increased kidney MDA displayed by FF animals may enhance kidney antioxidant activity and thereby attenuate both kidney damage and expression of LOX-1.
Homocysteine (Hcy) is a sulphydryl-containing amino acid derived from the demethylation of methionine. Hcy may be further metabolized by the sulphuration pathway to cysteine, or remethylated using either methyltetrahydrofolate or betaine, which is confined to the liver (Konukoglu et al. 2003) . Mild hyperhomocysteinaemia (HHcy), most commonly caused by diets poor in homocysteine-lowering vitamins, i.e. folate, vitamin B 6 and/or vitamin B 12 (Selhub et al. 1993; Moat et al. 2004) , occurs in approximately 5-7 % of the general population (McCully, 1996) . Recent studies have suggested that HHcy is a major independent risk factor for CVD (Konukoglu et al. 2003; Zhou et al. 2003) , with mild HHcy found in approximately 20 -30 % of patients with coronary, cerebrovascular and peripheral vascular disease (Malinow, 1990; Brattström & Wilcken, 2000; Stanger et al. 2001; Aamir et al. 2004; Fruchart et al. 2004) .
Some investigators have postulated that Hcy might cause atherosclerosis by damaging the endothelium either directly or by altering oxidative status. Endothelial Hcy-mediated cytotoxicity is, in part, attributable to the generation of reactive oxygen species, such as hydrogen peroxide (H 2 O 2 ), superoxide anion (O †2 2 ) and hydroxyl radical (HO †2 ; Misra, 1974) , during the auto-oxidation of Hcy to homocystine or other mixed disulphides (Starkebaum & Harlan, 1986; Welch et al. 1997; Heydrick et al. 2004) . The effect of HHcy on organ oxidative status has been investigated in endothelium (McCully, 1996; Morita et al. 2001) , liver (Huang et al. 2001) , heart (Young et al. 1997 ) and brain (Sachdev et al. 2004) , but little is known on the effect of this amino acid derivative on renal oxidative status. Some investigators have found that HHcy induced through different approaches did produce renal damage in both man and animals. Chen et al. (2002) and Li et al. (2002) reported the development of glomerulosclerosis in HHcy rats. Kumagai et al. (2002) found numerous renal lesions including tubular atrophy and interstitial fibrosis in rats with HHcy induced by feeding the animals a folate-deficient diet. While Fischer et al. (2003) reported an increase in lipid peroxidation in HHcy rats, the effect of HHcy on renal oxidative status and activity of antioxidant enzymes has not been investigated.
The goal of the present work was therefore first to induce HHcy status in rats by feeding the animals a folate-depleted diet, and second, to study the impact of this HHcy on renal oxidative status and antioxidant enzymatic competence.
Materials and methods

Animals, diets and experimental design
The animal protocol was approved by the Committee of Animal Care established at the Applied Pharmacobiology Research Center (APRC, University of Navarra, Pamplona, Spain) and was carried out in accordance with the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources Commission on Life Sciences, 1996). Twenty-five male Wistar albino rats (Rattus novergicus), bred at the APRC and weighing between 221 and 246 g, were housed in plastic-bottomed cages (PANLAB, Barcelona, Spain) in a room with controlled temperature (20^28C), relative humidity (45 %), laminar air flow and light -dark cycle (light from 08.30 to 20.30 hours). Water was freely available at all times. After being adapted to diets and cages for 3 d with free access to control diet, the rats were randomly divided into two groups of equal average weight. One group (FF, n 13) was fed a folate-free diet (Diets Inc., Bethlehem, PA, USA) following the criteria of Clifford and Kuory (Clifford et al. 1989) related to L-amino-acid-defined diets. The control group (CO, n 12) was fed the same diet but supplemented with 8 mg folic acid/kg, and was taken as control. Both diets contained 1 % succinyl sulphathiazole (w/w) to prevent folate production by intestinal microflora. Rats were weighed weekly and examined daily for general condition and symptoms associated with folate deficiency. On the first day and at the end of the 8-week feeding period, rats were lightly anaesthetized by intraperitoneal injection of 0·1 mg ketamine/g (Warner-Lambert Company, Morris Plains, NJ, USA) and blood samples were drawn from the retro-ocular venous plexus from all rats, with capillary tubes (Marienfeld, Mergenheim, Germany). Blood was centrifuged for 10 min at 3500 g, and plasma was stored at 2 808C until analyses.
At the end of the 8-week experiment, anaesthetized rats were killed by decapitation and kidneys were removed, weighed, and a portion was snap-frozen in liquid N 2 and kept frozen at 2 808C until analysis. The remaining tissue was embedded in formaldehyde for 24 h and then stored in alcohol. To prepare kidney homogenates, kidneys were thawed on ice and homogenized (1:10, w/v) in 20 mM-Tris -HCl containing 5 mM butylated hydroxytoluene and 0·01 % EDTA (Sigma, St. Louis, MO, USA) in an Ultraturrax blender. The homogenates were centrifuged at 3000 g for 10 min. Supernatants were then collected for malondialdehyde (MDA) analysis, and centrifuged at 20 000 g prior to determination of antioxidant enzyme activities.
Analytical procedures
Creatinine, cholesterol, glucose, triacylglycerols and NEFA were measured in plasma using an automatic autoanalyser (Cobas Mira ABX; Roche, Walpole, MA, USA). Plasma Hcy was measured as total Hcy by HPLC using a Hewlett Packard HP series 1050 instrument, model 79855A (ABX, Newark, CA, USA), according to Pfeiffer et al. (1999) . The inter-and intra-assay CV were , 10 %. Plasma folate concentrations were determined by RIA, with the aid of a commercially available kit (ABX; DPC, Madrid, Spain). The inter-and intra-assay CV were , 5 %.
Assessment of plasma and renal markers of oxidative stress. Levels of MDA, a validated index of lipid peroxidation (Esterbauer & Cheeseman, 1990) , were measured in plasma and kidney after heating samples at 458C for 60 min in acidic medium and quantified by colorimetric assay (Lipid Peroxidation Assay kit; Calbiochem, San Diego, CA, USA). The inter-and intra-assay CV were , 5 %. Superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities were measured in plasma and kidney homogenates at 378C in the Cobas Mira automatic analyser with the aid of commercially available kits (Ransel; Randox ABX, Barcelona, Spain). Total SOD activity, measured in diluted samples of kidney homogenate (1:100) and serum (1:50), was determined by a slightly modified method (McCord & Fridovich, 1987) where xanthine and xanthine oxidase were employed to generate superoxide radicals which react with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium. Data are expressed as U/mg protein using a standard provided in the kit and the inter-and intra-assay CV were ,5 %. GPx activities were measured in diluted samples of kidney (1:20) and serum (1:50) according to a previously described method (Paglia & Valentine, 1967) . Briefly, GPx catalyses the oxidation of glutathione by cumene hydroperoxide and in the presence of glutathione reductase and NADPH, the oxidized glutathione is immediately converted to the reduced form with a concomitant oxidation of NADPH to NADP þ . Values are expressed as U/mg protein. Inter-and intraassay CV were ,6 %. Protein oxidation, as measured by determination of protein carbonyl groups (PCC), was assessed by spectrophotometric assay as previously described (Stadtman & Oliver, 1991) . The inter-and intra-assay CV were ,5 %. Kidney concentrations of monocyte chemoattractant protein 1 (MCP-1), an indicator of initiation and progression of renal damage (Viedt & Orth, 2002) , were measured with a commercially available ELISA (r-MCP-1 Biotrake; Amersham Pharmacia Biotech, Amersham, Buckinghamshire, UK). The inter-and intra-assay CV were ,10 %. Western blotting analysis for oxidatively modified LDL receptor (LOX-1) was performed in kidney homogenate (Ox-LDLR-1; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA).
Histological examination and immunohistochemistry. Paraffin-embedded 3 mm thick sections of kidney were stained with periodic acid Schiff, haematoxylin and eosin, and Masson's monochrome, and optical light microscopy was performed at 10 £ and 40 £ magnification. A minimum of ten fields for each sample were examined by two independent observers. Approximately ten sections were examined in each kidney sample.
To explore oxidative damage, an immunohistological survey was performed. Paraformaldehyde-fixed renal tissue sections were analysed by indirect immunostaining with the primary antibodies against LOX-1, and with the biotinylated secondary antibody. Specificity of the primary antibody was confirmed by Western blotting. Sections of the antibody-labelled tissue were incubated with a streptavidin -horseradish peroxidase complex (Dako, Glostrup, Denmark) and developed with 3,3 0 -diaminobenzidine (Merck, Darmstad, Germany). Negative controls, using PBS in equal amounts for the primary antibody, were used.
Statistical analysis
Data are expressed as means with their standard deviations. Statistical significance was estimated with the paired or unpaired t test as appropriate. P, 0·05 was considered significant. All analyses were performed using the SPSS statistical package, version 9.0 (SPSS Inc., Chicago, IL, USA). Data were normally distributed for all measured variables. Kolmogorov-Smirnov and ShapiroWilk tests were applied in all cases. Fig. 1 shows that at the end of the 8-week experimental period, FF rats had a significantly lower body weight (P,0·001) than CO animals. The weight gain was 140·8 (SD 5·3) g in the CO group v. 106·1 (SD 5·3) g in the FF group.
Results
Animals
Folate and homocysteine status and biochemical parameters
As expected, at the beginning of the 8-week experimental period, plasma Hcy and folate concentrations did not differ between the two groups. After 8 weeks of dietary treatment, plasma folate decreased significantly (P, 0·001) while plasma Hcy concentrations increased significantly (P, 0·001) in FF animals compared with CO rats, corroborating an intermediate HHcy (Table 1) . A significant negative correlation was found between plasma folate and Hcy concentrations in the FF group (r 2 0·86, P¼0·01).
Plasma cholesterol and NEFA levels (Table 2) were significantly diminished in FF rats compared with CO animals, while no differences were observed in plasma creatinine between the two experimental groups. Fig. 2 shows significantly higher (P, 0·05) plasma MDA levels in the FF group (0·41 (SD 0·06) mmol/mg protein) than in CO rats (0·25 (SD 0·03) mmol/mg protein). Similarly, kidney MDA levels were significantly higher (P, 0·05) in FF animals (54·75 (SD 3·75) mmol/g tissue) compared with CO animals (45·31 (SD 2·51) mmol/g tissue).
Lipid peroxidation
Activities of antioxidant enzymes
Results related to oxidative stress parameters in kidney are shown in Fig. 3 . Renal activity of GPx in FF animals was significantly higher than in CO rats (P,0·001, 2·37 (SD 0·03) v. 2·14 (SD 0·03) U/mg protein). The same pattern was observed with SOD (P, 0·001, 23·7 (SD 0·5) v. 20·5 (SD 0·7) U/mg protein). In addition, significant correlations between plasma Hcy and folate concentrations and activity of both kidney antioxidant enzymes were found, with correlation values between renal SOD and plasma Hcy and folate of 0·531 (P,0·01) and 20·565 (P, 0·01), respectively, and for renal GPx of 0·685 (P, 0·01) and 2 0·732 (P,0·01), respectively. Plasma SOD and GPx activities were significantly higher (P,0·05) in FF rats than in the CO group (Fig. 4) .
Protein oxidation
Although a slight trend towards increased protein oxidation was observed in the FF animals where 7·26 (SD 1·05) mmol/mg protein compared with 6·67 (SD 0·66) mmol/mg protein in the CO group, these values were not significantly different.
Monocyte chemoattractant protein 1
The levels of MCP-1 in kidney measured by ELISA were not different between CO and FF groups, the values being 565·67 (SD 28·29) v. 535·30 (SD 26·9) pg/mg protein, respectively.
Histological changes
The histological evaluation showed a regular morphology in both groups and found no significant differences among the two experimental groups.
Oxidatively modified LDL receptor
A representative Western blot analysis in kidney homogenate using polyclonal antibody against LOX-1 demonstrated the Fig. 1 . Body weight changes of rats fed either a control, n 12 (V) or a folatefree n 13 (B) diet for 8 weeks. Values are means with their standard deviation shown by vertical bars. Mean values were significantly different from those of the control group: **P, 0·01, ***P, 0·001. Mean values were significantly different from those of the control group: ***P, 0·001. Mean values were significantly different from those of the control group: *P,0·05, **P,0·01.
presence of LOX-1 in this tissue, although because the Western assay was carried out under reducing conditions, protein denaturation most likely occurred creating the second band (Fig. 5 ).
Immunohistochemical analysis showed that LOX-1 was widely expressed in tubular cells, whereas there was almost no staining in the glomeruli (Fig. 6 ).
Discussion
The present study examined the chronic effects of diet-induced HHcy on the rat kidney. The first phase of the experiment involved the induction of intermediate HHcy by feeding rats a folate-free diet for 8 weeks. Following this depletion phase and in agreement with previous investigators (Clifford et al. 1990) , the parameters measured were sensitive enough to distinguish between folate-depleted and folate-repleted animals. Mean plasma folate concentrations in the folate-depleted rats (1·87 ng/ml) were slightly lower than the values obtained by other authors (O'Leary & Sheehy, 2001 ). The mean plasma Hcy concentrations of depleted rats (75·36 mmol/l) were similar to those reported by Miller et al. (1994) . The inverse relationship between plasma Hcy and folate intake found in the present study was also consistent with previous reports in rats (Durand et al. 1996) . The dietary model used in the present study, as compared with other designs (Southern et al. 1998; Morita et al. 2001; Kumagai et al. 2002) , may be of relevance because clinically or sub-clinically low folate levels are commonly caused by nutritional folate deficiency (Lentz, 1997) .
The reduced weight gain displayed by FF rats correlated with previous reports (Clifford et al. 1989 (Clifford et al. , 1990 Balaghi et al. 1993; Huang et al. 2001 ), but contrasted with others (Durand et al. 1996 (Durand et al. , 1997 . These differences in growth response might be related to the level of folate restriction and the length of the experimental periods.
There were no differences in serum creatinine between groups, which echoes the results obtained by Rolland et al. (1995) who demonstrated no significant alteration in creatinine clearance in hyperhomocysteinaemic minipigs. This may indicate that glomerular filtration rate had not been altered under these experimental conditions. The decrease of plasma NEFA and cholesterol found in the present study could be attributed to either the low folate status (Akesson et al. 1982) or the HHcy condition. The fact that plasma cholesterol, triacylglycerols and NEFA levels were reduced in FF rats correlates with the findings of Werstuck et al. (2001) , who demonstrated that Hcy-induced endoplasmic reticulum stress causes dysregulation of the endogenous sterol response pathway.
Regarding the effect of plasma levels of Hcy on kidney morphology, HHcy induced through different approaches has been found to produce renal damage in both human and animal subjects. These include glomerulosclerosis Li et al. 2002; Yang & Zou, 2003) , tubular atrophy and interstitial fibrosis (Miller et al. 2000; Kumagai et al. 2002) in rats in which HHcy was induced by feeding the animals a diet deficient in folate. However, we observed no relevant histological differences in the FF rats, probably because the 8-week period was Fig. 2 . Effects of hyperhomocysteinaemia on malondialdehyde (MDA) levels in (A) plasma and (B) kidney tissues after 8 weeks for rats in the control (CO, n 12) and folate-free (FF, n 13) groups. Values are means with their standard deviation shown by vertical bars. Mean values were significantly different from those of the CO group: *P, 0·05. Fig. 3 . Renal effects of hyperhomocysteinaemia on activity of (A) glutathione peroxidase (GPx) and (B) superoxide dismutase (SOD) after 8 weeks for rats in the control (CO, n 12) and folate-free (FF, n 13) groups. Values are means with their standard deviation shown by vertical bars. Mean values were significantly different from those of the CO group: ***P, 0·001. too short to produce morphological alterations in kidney. Nevertheless, these results correlate with those of Rensma et al. (2003) who found no evidence of significant renal damage in patients displaying both homocystinuria and strongly elevated plasma Hcy levels (. 100 mmol/l).
The present study provided evidence that lack of folate consumption is also associated with increased oxidative damage in kidney. Lipid peroxidation is a well-established mechanism of cellular injury. This reaction leads to the production of lipid peroxides and their by-products, and ultimately to the loss of membrane function and integrity (Turrens et al. 1982) . A major secondary oxidation product of PUFA is MDA (Esterbauer & Cheeseman, 1990) , a substance that is frequently measured as thiobarbituric acid-reactive substances (TBARS) to assess the degree of peroxidation (Huang et al. 2001; Raijmakers et al. 2003) . Because the TBARS test is not specific for MDA (Janero, 1990) , we employed a new more specific colorimetric assay. As compared with CO animals, FF rats exhibited greater MDA levels in kidney, indicating an increased renal lipid peroxidation, which correlates with the results of other investigators (Fischer et al. 2003) . Other studies have also found significantly higher TBARS production in liver of folate-depleted rats as compared with normally fed animals (Huang et al. 2001) , and elevated MDA levels have also been found in the heart of pigs with induced HHcy (Young et al. 1997) . On the other hand, the results of the present work also correlated with those of Ventura et al. (2000) , who demonstrated a significant increase in plasma markers of lipid peroxidation in rats with HHcy induced by an oral methionine loading.
No differences in kidney PCC levels between the two groups were found in the present study. References on this matter are few and contradictory. Assessment of kidney PCC in HHcy subjects has not been found in the literature. Ventura et al. (2000) demonstrated an elevation of plasma PCC in acute HHcy after methionine loading. Nevertheless, Raijmakers et al. (2003) were recently unable to detect changes in plasma PCC in similar conditions. Nagase et al. (2001) demonstrated that Hcy exerts its effects through oxidative stress, and by enhancement of endothelial LOX-1 gene expression. They also observed that this expression was inhibited by antioxidants like Tempol, a SOD mimetic, which alleviated LOX-1 augmentation induced by angiotensin II. However, the current immunohistochemical assessment revealed that LOX-1 was expressed in tubular cells but no differences were seen between FF rats and CO animals. Certainly, it could be expected that increased Hcy levels might cause enhanced LOX-1 expression, but it seems likely that the outstanding increase in antioxidant enzymes observed in the present study could inhibit LOX-1 expression.
In vitro studies have demonstrated that Hcy enhances the production of several pro-inflammatory cytokines. Expression of MCP-1 is increased in cultured human vascular endothelial cells and monocytes treated with Hcy (Lawrence de Koning et al. 2003) ; however, the results of the present experiment showed no differences in MCP-1 levels between CO and FF rats. The protective effect of enhanced antioxidant enzymes, together with the relatively short time of FF induction, may also explain such lack of MCP-1.
Regarding the renal damage caused by HHcy, current data (Friedman et al. 2001) suggest that the healthy kidney plays a major role in Hcy clearance and metabolism. Hcy levels increase as renal function declines and progresses to end-stage renal disease. In the present study, renal oxidative damage has been found in rats in which HHcy status has been induced by feeding the animals a depleted folate diet. In the case of renal failure patients, HHcy might worsen the course of the disease. A vicious circle would be created in these patients between HHcy and the progression of renal failure (Bostom et al. 1995; Perna et al. 2001; Kumagai et al. 2002) .
An enhancement of plasma antioxidant enzyme activity has been shown in the FF rats, as compared with CO animals. In this sense, it is worth pointing out that Moat et al. (2000) explored Fig. 4 . Effects of hyperhomocysteinaemia on plasma activity of (A) glutathione peroxidase (GPx) and (B) superoxide dismutase (SOD) after 8 weeks for rats in the control (CO, n 12) and folate-free (FF, n 13) groups. Values are means with their standard deviation shown by vertical bars. Mean values were significantly different from those of the CO group: *P, 0·05. the activity of plasma antioxidant enzymes in patients who displayed elevated plasma total Hcy concentrations as a result of inherited defects of Hcy metabolism. Their results suggested that elevated plasma Hcy represents a status of increased oxidative stress, which triggers an adaptive response by increasing the activity of antioxidant enzymes in the circulation. The current study shows, for the first time, that an increase in oxidative stress in kidney induced by HHcy secondary to a complete dietary folate restriction caused a marked increase in the activities of both SOD and GPx. This suggests that a mechanism of homeostatic adaptation might come into play, in which a process of SOD and GPx up-regulation, i.e. enhanced enzymatic protein expression, could represent a protective antioxidant mechanism . It has been recently shown (Sindhu et al. 2005) that the oxidative stress induced in aortic tissue by hypertension is accompanied by an up-regulated increase in the expression of a number of antioxidant enzymes, such as NADPH oxidase, catalase, Cu/Zn-SOD and Mn-SOD, although these authors did not find changes in GPx. They postulated that up-regulation of antioxidant enzymes may be a compensatory response in the face of oxidative stress.
In conclusion, the present study provides evidence that HHcy produces a renal oxidative stress mediated by lipid peroxidation, but not by protein oxidation. The increase of MDA in the kidney is parallel to a rise in antioxidant enzyme activity that probably attenuates kidney damage by reducing the expression of LOX-1 and MCP-1, two main mediators of endothelial dysfunction. Antioxidant therapy might be a convenient therapeutic approach to prevent kidney damage in HHcy subjects.
